While their analyses did not provide specific P values, they identified two CpGs within the PD‐L1 promoter (cg15837913 and cg19724470) that exhibited differential methylation patterns between normal brains and tumors as well as IDH‐mutant and wildtype gliomas. This evidence concerns the gene IDH2 and central nervous system cancer.